North Macedonia's investment company Best Way Investment and diversified group Orka Holding are seeking for approval to ...

A high-performance tech can reportedly provide a comprehensive picture of the underwater acoustic environment, ...

Thales, will provide a comprehensive suite of high-performance sonar systems for the future Orka-class of submarines ...

Healthcare Capital Partners III, L.P. Venrock, a 10% owner of $ORKA, bought 88,794 shares of the company on 02-14-2025 for an estimated $1,015,803. This trade was ...

Thales has signed a deal with Naval Group to supply the sonar suite for the Orka-class diesel-electric submarines that will ...

The Royal Netherlands Navy future Orka-class submarines will feature an advanced sonar suite OptiArray technology from ...

The suite will include bow, flank, and obstacle-avoidance sonars, an intercept array, a passive towed-array sonar, and more.

Detailed price information for Oruka Therapeutics Inc (ORKA-Q) from The Globe and Mail including charting and trades.

Detailed price information for Oruka Therapeutics Inc (ORKA-Q) from The Globe and Mail including charting and trades.

The company has initiated a Phase 1 trial for ORKA-001, targeting IL-23p19, with pharmacokinetic data expected in the second half of 2025, and plans to begin a Phase 2a trial later that year.

Patients with psoriatic arthritis exhibit high levels of both IL-17A and IL-17F cytokines in the synovium. Bimekizumab, a biologic that targets both IL-17A and IL-17F, was recently approved for the ...

A five-year £19.2m loan from Secure Trust Bank has recapitalised the 242-bed asset, bought by Orka Investments in 2023 and ...